At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. With over 100 years of scientific heritage, we actively focus on developing innovative treatments for patients in five important therapeutic areas of healthcare: oncology, immunology, neuroscience, infectious diseases & vaccines and cardiovascular & metabolic diseases. Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with patient organisations, healthcare professionals and the NHS; based on partnerships of trust and transparency. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more about Janssen-Cilag Limited at: http://www.janssen.com/uk. Follow us on Twitter: @JanssenUK.
Pfizer: Transforming UK health, one patient at a time
Pfizer is committed to supporting healthcare quality improvement initiatives and research. In 2016, Pfizer spent over £250 million supporting research and development carried out in the UK and contributed to 162 collaborations with universities, pharmaceutical companies, industries and others. Through such collaborations and sharing knowledge, skills and expertise, Pfizer aim to improve the health and lives of people in the UK and around the world.
Complementing Pfizer’s long-standing commitment to innovative research and development, Pfizer also supports healthcare organisations, academic institutions, charities, patient organisations, community organisations, and professional societies through donations. Pfizer also actively supports the scientists of tomorrow, through the National Apprenticeship Programme, its undergraduate placement scheme and through various STEM (Science Technology Engineering and Mathematics) and SIP (Science Industry Partnership) activities.
This activity has been supported by grants from the following companies. They have had no control over the educational content of this activity.
Roche Products Limited